DRIO Stock UPDATES Labstyle (DRIO) 0.1030 09/04/2014 19:41:5

New Post Public Reply Private Reply Replies (0) Message Board

Sep 4, 2014 at 8:41 PM

Labstyle (DRIO) 0.1030 $DRIO

OTC Daily Trading News: Evoq Properties, Inc. MedBox, Inc. LabStyle Innovations Corp, MyEcheck, Inc. Elite Pharmaceuticals, Inc.
PR Newswire Europe - Tue Aug 19, 10:11AM CDT
LONDON, August 19, 2014 /PRNewswire/ --

LabStyle Innovations Reports 2014 Second Quarter Results and Anticipated Milestones for the Remainder of the Year
PR Newswire - Fri Aug 15, 8:05AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today reported its financial and operational results for the three and six months period ending June 30, 2014. The company also presented an overview of results of the Dario(TM) smart meter soft launch, recent corporate achievements and anticipated milestones for the remainder of 2014.

LabStyle Innovations Announces the Initial Launch of the Dario(TM) Diabetes Management Solution for Android Devices
PR Newswire - Thu Jul 31, 8:50AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, announced today that the company has released the Dario(TM) Diabetes Management App for Android smartphone users. The mobile application will have the same user interface and features as the iOS Dario(TM) Application and will be available in select soft launch markets, including the United Kingdom and New Zealand.

LabStyle Innovations wins Israeli Ministry of Health's approval to market the Dario Smart Meter to people living with diabetes in Israel
M2 - Tue Jul 29, 6:09AM CDT
Diabetes management company LabStyle Innovations (Other OTC

RIO) disclosed on Monday the receipt of the Israeli AMAR's approval for the marketing and sale of the Dario Smart Meter in Israel.

LabStyle Innovations Receives Israeli Ministry of Health Approval for the Dario(TM) Smart Meter
PR Newswire - Mon Jul 28, 8:05AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, announced today that it has received approval from the Israeli AMAR for the marketing and sale of the Dario(TM) Smart Meter in Israel. The Israeli AMAR is a unit in the Ministry of Health and is responsible for certification of all activities concerning medical devices import, sale and export and is a precondition for the sale of medical devices in Israel.

LabStyle Innovations Corp.'s CEO Erez Raphael Interviewed by The Life Sciences Report
Marketwire - Thu Jul 17, 8:25AM CDT
Having a chronic disease like diabetes engenders a sense of isolation that hasn't been adequately addressed by technology until now. With Dario, LabStyle Innovations Corp. (OTCQB: DRIO) has created a device that not only provides vital medical information to a diabetic patient in real time, but also connects that patient to a community of care providers, family, and online resources. In this interview with The Life Sciences Report, LabStyle President and CEO Erez Raphael describes how the Dario software platform could provide sufferers of other chronic diseases with the benefits of real-time data and community as well.

LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors
PR Newswire - Thu Jul 10, 11:00AM CDT
LabStyle Innovations Corp. (OTCQB

RIO), developer of the Dario(TM) Diabetes Management Solution, today announced the appointment of Professor Richard B. Stone as an independent member of its Board of Directors.

LabStyle Innovations to distribute its Dario Smart Meter, test strips and lancets in the Netherlands through Viper Medical
M2 - Thu Jul 10, 7:35AM CDT
LabStyle Innovations (OTCQB

RIO), a mobile health company that provides laboratory-testing products, reported on Wednesday the launch of an exclusive distribution agreement for its Dario Smart Meter, test strips and lancets in the Netherlands through Viper Medical.

LabStyle Innovations to Commence Sales of Dario(TM) in the Netherlands
PR Newswire - Wed Jul 09, 8:05AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, announced today that the company is increasing its market reach by entering into an agreement with Viper Medical for exclusive distribution of the Dario(TM) Smart Meter, test strips and lancets in the Netherlands.

Falling Earnings Estimates Signal Weakness Ahead for Hansen Medical (HNSN) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jul 01, 7:35AM CDT
Hansen Medical one such stock considered to drop as it has witnessed a significant price decline and has seen negative earnings

LabStyle Innovations signs strategic distribution agreement in Canada for Dario Smart Meter, test strips and lancets
M2 - Mon Jun 30, 2:13AM CDT
Patented technolgy company LabStyle Innovations (Other OTC

RIO) reported on Friday the launch a strategic distribution agreement to grant the exclusive right to distribute the Dario Smart Meter, test strips and lancets in Canada to AutoControl Medical (ACM) .

LabStyle Innovations to Commence Sales of the Dario(TM) Smart Meter in North America
PR Newswire - Fri Jun 27, 8:05AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, announced today that it has entered into a strategic distribution agreement with AutoControl Medical Inc. (ACM) that grants ACM the exclusive right to distribute the Dario(TM) Smart Meter, test strips and lancets in Canada.

LabStyle Innovations Awarded NHS Reimbursement Status in the United Kingdom for the Dario(TM) Smart Meter Strips and Lancets
PR Newswire - Wed Jun 25, 8:53AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO)announced today that it has been granted reimbursement status for strips and lancets to be utilized together with the patented Dario(TM) Smart Meter, effective September 1, 2014 in England, Wales, Scotland and Northern Ireland. Dario(TM) is a cloud-based, diabetes management solution which includes novel software applications combined with the stylish, 'all-in-one', pocket-sized, Dario Smart Meter which interfaces with a user's mobile device to form the overall Dario(TM) Diabetes Management Solution, allowing diabetics to monitor their blood sugars and other activities using their mobile devices.

LabStyle Innovations Reports Positive Results From the Initial Commercial Launch of Dario(TM) Smart Meter
PR Newswire - Tue Jun 17, 8:20AM CDT
LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today provided a positive update on the initial "soft" launch of the Dario(TM) Smart Meter in the company's initial target jurisdictions of the United Kingdom, Italy and New Zealand.

Renowned Diabetes Authority Dr. William Polonsky Joins LabStyle Innovations Medical/Scientific Advisory Board
PR Newswire - Wed Apr 02, 6:15AM CDT
LabStyle Innovations Corp. (OTCQB

RIO), developer of the Dario(TM) Diabetes Management Solution, today announced the appointment of Dr. William Polonsky to its Scientific/Medical Advisory Board.

IPOs and Transactions: March 17 - 21
PR Newswire - Mon Mar 24, 11:30AM CDT
There were 56 transactions filed with the SEC last week. Highlighted corporations and law firms include:

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

HONGQI's EHS4 Launch in Europe: Bridging East and West

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

WHO and RCSI Bahrain Join Forces on Health Initiatives

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

BETR's Slide: Investors Face Big Losses, Leadership Shift

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Uber Data Breach: Class Action Investigation Begins

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Webull Faces Class Action: Key Details for Investors

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...